Castle Biosciences (CSTL) Intangibles (2018 - 2022)
Castle Biosciences (CSTL) posted Intangibles of $87.3 million for Q1 2022, down 1.85% sequentially from $88.9 million in Q4 2021.
Castle Biosciences (CSTL) Intangibles (2018 - 2022) Analysis & Trends
Castle Biosciences has reported Intangibles for 3 years, with the latest figure at $87.3 million in Q1 2022.
- Quarterly Intangibles changed N/A year-over-year to $87.3 million in Q1 2022, while the trailing twelve-month figure through Mar 2022 was $87.3 million (changed N/A YoY) and the FY2021 annual result came in at $88.9 million, changed N/A from the prior year.
- Intangibles fell to $87.3 million in Q1 2022 per CSTL's latest filing, from $88.9 million in the prior quarter.
- Over five years, Intangibles peaked at $88.9 million in Q4 2021 and troughed at $4000.0 in Q4 2018.
- A 3-year average of $48.2 million and a median of $32.8 million in 2021 frame the typical range for Intangibles.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 18.61 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 21.36 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | 98.17 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | 407.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 4.75 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 367.36 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 410.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 266.26 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 1.67 Bn |
| 10 | Castle Biosciences | 926.56 Mn | 659.75 Mn | 79.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 87.28 Mn |
| Dec 31, 2021 | 88.92 Mn |
| Sep 30, 2021 | 32.10 Mn |
| Jun 30, 2021 | 32.80 Mn |
| Dec 31, 2018 | 4,000.00 |